IRIS
FOSCHI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 802
EU - Europa 741
NA - Nord America 622
SA - Sud America 119
AF - Africa 18
OC - Oceania 3
Totale 2.305
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 603
SG - Singapore 434
RU - Federazione Russa 267
IT - Italia 238
HK - Hong Kong 220
BR - Brasile 110
CN - Cina 75
DE - Germania 53
NL - Olanda 50
FI - Finlandia 35
FR - Francia 24
AT - Austria 20
IN - India 16
IE - Irlanda 14
CA - Canada 13
GB - Regno Unito 13
IR - Iran 11
AE - Emirati Arabi Uniti 8
ET - Etiopia 7
IQ - Iraq 7
ZA - Sudafrica 6
BE - Belgio 5
AR - Argentina 4
CH - Svizzera 4
ID - Indonesia 4
BD - Bangladesh 3
EC - Ecuador 3
IL - Israele 3
JP - Giappone 3
KR - Corea 3
LT - Lituania 3
RO - Romania 3
SA - Arabia Saudita 3
AU - Australia 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
MX - Messico 2
SE - Svezia 2
TN - Tunisia 2
TR - Turchia 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
KZ - Kazakistan 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
SC - Seychelles 1
TH - Thailandia 1
TW - Taiwan 1
UA - Ucraina 1
VE - Venezuela 1
VN - Vietnam 1
Totale 2.305
Salva come PNG Salva come JPEG
Città #
Hong Kong 213
Santa Clara 203
Singapore 199
Boardman 132
Moscow 59
Verona 35
New York 32
Helsinki 26
L’Aquila 24
West Jordan 22
Shanghai 20
Ashburn 18
Benevento 18
Los Angeles 15
Milan 14
Dublin 12
Kitzingen 11
Spoltore 11
Chandler 10
Nuremberg 9
Bologna 8
Dallas 8
Lappeenranta 8
Amsterdam 7
Naples 6
Pescara 6
Rio de Janeiro 6
Curitiba 5
Falkenstein 5
Pontedera 5
Ravenna 5
São Paulo 5
Vienna 5
Brussels 4
London 4
Mumbai 4
Toronto 4
Turin 4
Abu Dhabi 3
Addis Ababa 3
Bauru 3
Beijing 3
Belo Horizonte 3
Berlin 3
Brasília 3
Campinas 3
Catania 3
Fort Worth 3
Frankfurt am Main 3
Montreal 3
Ottawa 3
Pretoria 3
Rome 3
São José dos Campos 3
Tehran 3
Teramo 3
Assago 2
Atlanta 2
Awasa 2
Brno 2
Canoas 2
Caserta 2
Columbus 2
Del Norte 2
Gangnam-gu 2
Guangzhou 2
Itaquaquecetuba 2
Lambeth 2
Lucca 2
Matelica 2
Mexico City 2
Napa 2
Padova 2
Palermo 2
Paris 2
Presidente Prudente 2
Qom 2
Regensburg 2
Seriate 2
Stockholm 2
São José do Rio Preto 2
Tashkent 2
Vallefoglia 2
Venice 2
Vitória 2
Zurich 2
Alexandria 1
Alta Floresta 1
Anicuns 1
Aparecida 1
Araci 1
Auckland 1
Baghdad 1
Bahir Dar 1
Baixo Guandu 1
Baku 1
Barbacena 1
Barinas 1
Basra 1
Bhubaneswar 1
Totale 1.310
Salva come PNG Salva come JPEG
Nome #
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 97
Acute stroke-like deficits associated with nonketotic hyperglycemic hyperosmolar state: an illustrative case and systematic review of literature 58
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 54
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 53
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 50
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 49
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 44
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 38
Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine 37
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 34
Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy 34
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 33
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 31
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 31
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 31
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 30
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 30
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 30
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 29
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 28
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 28
Stress hyperglycemia is associated with futile recanalization in patients with anterior large vessel occlusion undergoing mechanical thrombectomy 28
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 28
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 28
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis 27
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 27
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 27
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 26
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 25
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 25
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 24
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 24
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 23
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study 22
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 22
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 22
Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 22
Teeth loss after teriflunomide treatment: Casual or causal? A short case series 22
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 22
Neurological abnormalities in individuals with Marfan syndrome: results from a genetically confirmed Italian cohort 22
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship 22
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort 21
Editorial: CSF and blood biomarkers in COVID-19 and other neuroinfectious diseases 21
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 21
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 21
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 20
Comparison of Drip‐and‐Ship Versus Mothership Delivery Models of Mechanical Thrombectomy Delivery 20
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 20
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study 20
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 20
“NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab” 19
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 19
Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review 19
Another Nail in the Coffin of Causality for the Diastolic Blood Pressure J Curve 19
A call for academic pragmatic clinical trials to address open questions in migraine prevention 19
Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis 18
The multifaceted role of neurofilament light chain protein in non-primary neurological diseases 18
Blood GFAP as an emerging biomarker in brain and spinal cord disorders 18
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence 18
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 18
A 36-Year-Old Woman With Right Eye Ptosis 18
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis 18
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic 18
Migraine with aura, thrombophilia, and the debate on white matter hyperintensities 18
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) 18
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 17
Clinicoradiological Profile and Functional Outcome of Acute Cerebral Venous Thrombosis: A Hospital-Based Cohort Study 17
Guillain-Barré syndrome following COVID-19: new infection, old complication? 17
Arthritic psoriasis during natalizumab treatment: a case report and review of the literature 17
Diagnostic and Prognostic Blood Biomarkers in Transient Ischemic Attack and Minor Ischemic Stroke: An Up-To-Date Narrative Review 17
Site and type of craniopharyngiomas impact differently on 24-hour circadian rhythms and surgical outcome. A neurophysiological evaluation 17
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 17
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review 17
Neurofilament light chain and glial fibrillary acidic protein as diagnostic and prognostic biomarkers in epileptic seizures and epilepsy: A systematic review 17
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable 16
Identifying Cladribine prescription pattern in MS: an Italian multicentre study 16
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 16
Predictors of futile recanalization in nonagenarians treated with mechanical thrombectomy: a multi-center observational study 16
Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome 16
Outcomes of mechanical thrombectomy in orally anticoagulated patients with anterior circulation large vessel occlusion: a propensity-matched analysis of the Imperial College Thrombectomy Registry 16
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation 15
Left atrial appendage thrombosis in a patient with Friedreich Ataxia-related cardiomyopathy, left ventricular systolic dysfunction, and atrial fibrillation 15
Prospective observational cohort study of early recurrent TIA: Features, frequency, and outcome 15
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas 15
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 15
Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome 15
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD 14
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study 14
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis 14
Global Burden of Cardiovascular Diseases and Risks, 1990-2022 14
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study 14
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register 14
Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease 13
Safety and outcomes of different endovascular treatment techniques for anterior circulation ischaemic stroke in the elderly: data from the Imperial College Thrombectomy Registry 13
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies 13
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies 12
Broadening the Spectrum of Adulthood X-Linked Adrenoleukodystrophy: A Report of Two Atypical Cases 12
Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium? 12
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis 12
Author Response: Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome 11
Totale 2.317
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.245
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 0 7 1 3
2022/202390 1 2 0 3 3 4 0 2 12 1 5 57
2023/2024391 6 10 16 47 22 47 3 3 3 85 63 86
2024/20251.952 106 28 195 99 229 178 292 205 620 0 0 0
Totale 2.444